Jellagen dispatches JellaGel™, the principal Collagen Type 0 Hydrogel taking available driving Extracellular Matrix Kumar Jeetendra | January 15, 2021 Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels make it possible for cells to grow and interact with all of their surroundings that makes a massive difference. Cells grown in a 3D model have been shown to be more natural, with …
India needs Pfizer to do nearby examination for approval: Official Kumar Jeetendra | January 13, 2021 Any vaccine manufacturer, such as Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must run a neighborhood”bridging” safety and immunogenicity study to be considered for the country’s immunisation programme, a senior government official told Reuters. Serum Institute of India, the local maker of the vaccine developed by AstraZeneca Plc and …
Granules India gets USFDA endorsement for Metformin Hydrochloride ER tablets Kumar Jeetendra | January 13, 2021 Granules India Limited today announced that United States Food & Drug Administration (USFDA) has given the final approval for its abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1,000 mg. These tablets are the generic equivalent of Glumetza ER tablets, 500 mg & 1,000 milligrams of Bausch Health US …
Cipla to Present at the 39th Annual J.P. Morgan Healthcare Conference Kumar Jeetendra | January 12, 2021 India; January 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 39th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry. Mr. Umang Vohra, MD and Global CEO, Cipla, will virtually present a corporate overview of the …
Dr Reddy’s’ dispatches generic medication in the US market Kumar Jeetendra | January 11, 2021 New Delhi, Jan 11 (PTI) Dr Reddy”s Laboratories on Monday said it has launched Febuxostat tablets, used to treat gout due to high uric acid levels, in the US market. The company has launched the product, which is a generic version of Teijin Ltd”s Uloric tablets, after getting approval from the US Food and Drug …
Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US Kumar Jeetendra | January 10, 2021 New Delhi, Jan 10 (PTI) Drug major Cipla is recalling more than 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market, as per a report from the US Food and Drug Administration. The medication major is recalling esomeprazole magnesium for delayed-release oral suspension in unit …
Lupin gets USFDA gesture to market generic of sulfamethoxazole, trimethoprim Kumar Jeetendra | January 10, 2021 New Delhi, Jan 6 (PTI) Homegrown pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic version of sulfamethoxazole and trimethoprim oral suspension used in the treatment of bacterial infections. Sulfamethoxazole and trimethoprim oral suspension, 200 mg/40 mg per 5 mL, is indicated for the …
Biotech Team Develops ELISA Protocol for COVID-19 IgG Antibody Detection Kumar Jeetendra | January 7, 2021 Budapest, HU – 6 January 2021 – ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease. Early …
FDA confirms resubmission new drug application of Alkermes Kumar Jeetendra | January 3, 2021 Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the company’s New Drug Application (NDA) resubmission for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults with schizophrenia and adults with bipolar I disorder, and has assigned the application a new Prescription Drug User Fee Act (PDUFA) target action date …
... Kumar Jeetendra | January 2, 2021 New Delhi: Drug important Glenmark Pharma on Thursday said it has received final approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate. The business also received two tentative approvals in the US health regulator. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and …
Zydus Cadila gets DCGI gesture for NAFLD drug in India Kumar Jeetendra | December 30, 2020 New Delhi, Dec 30 (PTI) Drug firm Zydus Cadila on Wednesday said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the nation. Zydus Cadila explained the prevalence of NAFLD in India is estimated to be nearly 25-30 …
Lupin receives tentative nod from USFDA for its toenail fungus remedy topical solution Kumar Jeetendra | December 25, 2020 NEW DELHI: Drug company Lupin on Thursday said it has received tentative nod in the US health regulator to market generic Efinaconazole topical solution used for treatment of fungal infections of toenails. The business has received tentative approval to market its Efinaconazole topical solution, 10%, by the United States Food and Drug Administration (USFDA), Lupin …